MARIA SILVA: Open Payments
NPI 1215604731 · DONNA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 40 payments from 11 companies in 2025. Trend: 2023 $230 · 2024 $759 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $407 |
| Lilly USA, LLC | 11 | $218 |
| Boston Scientific Corporation | 1 | $138 |
| Madrigal Pharmaceuticals | 1 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $93 |
| Dexcom, Inc. | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: Wegovy, ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter, REZDIFFRA, Kerendia, Dexcom G6 Transmitter, Rybelsus, MOUNJARO, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
